Skip to main content

Specialty

Urology

Language(s) Spoken

English

Joined Kelsey-Seybold

September 2020

Accepting New Patients?

Yes

Professional Background

Dr. Christopher Hobaugh completed his Bachelor of Science in biology, summa cum laude, at Texas A&M University in College Station in 2011. He earned his medical degree in 2015 at McGovern Medical School at The University of Texas Health Science Center at Houston. In 2020, he completed his residency in Urology at Baylor College of Medicine in Houston. He joined Kelsey-Seybold in September 2020.

Professional Associations

Dr. Hobaugh is a member of the American Urological Association and the Harris County Medical Society.

Hobbies and Interests

Dr. Hobaugh enjoys spending time with his family, hiking, and fishing.

Fun Facts

Dr. Hobaugh wanted to be a physician even as a child. Some of the best advice he received was a quote by American poet Maya Angelou: “People will forget what you said, people will forget what you did, but people will never forget how you made them feel.”

​I believe every patient is unique and has individualized priorities and preferences. My goal as a physician is to help my patients understand their disease and understand their available treatment options. Then we can make a decision that’s best for each individual and their health.

​​​​​​​​​​​​By Phone

Our Contact Center is here to serve you, 24 hours a day, 7 days a week.



713-442-0427​​​​
​​


Awards & Recognitions

  • Scott Department of Urology Resident Teacher of the Year, 2020

  • Alpha Omega Alpha Honor Medical Society, 2015

  • National Merit Finalist, National Merit Scholarship Program, 2007

  • Texas A&M President’s Endowed Scholar, 2007 - 2011

Publications

  • Jones JA, Hobaugh CW, Salvas DB, Bennett RM, Godoy G, Donohue JP. Outcomes in patients with testicular maldescent and germ cell neoplasia: A retrospective assessment and review of the literature. Urol Androl Open J 2(1): 8 - 18, 2018.

  • Hobaugh C, Pastuszak AW. Serious complications of collagenase clostridium histiolyticum injection for Peyronie's disease: more than meets the eye. Transl Androl Urol 6(2):320 - 21, Apr 2017.

  • Warburton D, Hobaugh C, Wang G, Lin H, Wang R. Testosterone replacement therapy and the risk of prostate cancer. Asian J Androl 17(6):878 - 81, Nov 2015.

  • Garvey PB, Selber JC, Hobaugh CW, Hong Z, Baumann DP, Butler DP. Tissue Expanders Experience Fewer Complications When Skin Flaps are Assessed with Laser Fluorescent Angiography Rather than Clinical Judgment Alone. Plast Reconstr Surg 131(5S):45, May 2013.

Presentations

Hobaugh CW. T. Leon Howard Case Presentation: Uretero-iliac artery fistula. South Central Section of the American Urological Association, September 2017.